In vivo immune programming for autoimmune and cancer
CREATE Medicines (formerly Myeloid Therapeutics) is a clinical-stage biotechnology company pioneering in vivo immune programming. Its proprietary mRNA-LNP platform engineers T cells, NK cells, and myeloid cells directly inside the body — enabling repeat-dose, off-the-shelf CAR therapies without ex vivo manufacturing. The company has dosed more than 50 patients across its in vivo CAR programs in autoimmune disease and oncology, the largest clinical dataset in the field.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2026
May 2023
Create a free account to see which investors have funded this company.
Create Free Account
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
